SE9400810D0 - New use of Quinoline-3-carboxamide compounds - Google Patents

New use of Quinoline-3-carboxamide compounds

Info

Publication number
SE9400810D0
SE9400810D0 SE9400810A SE9400810A SE9400810D0 SE 9400810 D0 SE9400810 D0 SE 9400810D0 SE 9400810 A SE9400810 A SE 9400810A SE 9400810 A SE9400810 A SE 9400810A SE 9400810 D0 SE9400810 D0 SE 9400810D0
Authority
SE
Sweden
Prior art keywords
quinoline
pct
psoriasis
atoms
treating psoriasis
Prior art date
Application number
SE9400810A
Other languages
English (en)
Swedish (sv)
Inventor
Agneta Svedberg
Per Gjoerstrup
Bo Nilsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9400810A priority Critical patent/SE9400810D0/xx
Publication of SE9400810D0 publication Critical patent/SE9400810D0/xx
Priority to IL11290995A priority patent/IL112909A0/xx
Priority to IL11290895A priority patent/IL112908A0/xx
Priority to AU20887/95A priority patent/AU679633B2/en
Priority to JP7523404A priority patent/JPH09510199A/ja
Priority to EE9600127A priority patent/EE9600127A/xx
Priority to CA002185135A priority patent/CA2185135A1/en
Priority to EP95913458A priority patent/EP0749310A1/en
Priority to US08/704,587 priority patent/US5726183A/en
Priority to PCT/SE1995/000245 priority patent/WO1995024196A1/en
Priority to ZA951966A priority patent/ZA951966B/xx
Priority to FI963531A priority patent/FI963531A0/fi
Priority to NO963762A priority patent/NO963762D0/no
Priority to KR1019960704979A priority patent/KR970701546A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9400810A 1994-03-10 1994-03-10 New use of Quinoline-3-carboxamide compounds SE9400810D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9400810A SE9400810D0 (sv) 1994-03-10 1994-03-10 New use of Quinoline-3-carboxamide compounds
IL11290995A IL112909A0 (en) 1994-03-10 1995-03-07 Novel use of quinoline-3-carboxamide compounds
IL11290895A IL112908A0 (en) 1994-03-10 1995-03-07 Pharmaceutical compositions containing quinoline-3-carboxamide compounds
PCT/SE1995/000245 WO1995024196A1 (en) 1994-03-10 1995-03-08 New use of quinoline-3-carboxamide compounds
CA002185135A CA2185135A1 (en) 1994-03-10 1995-03-08 New use of quinoline-3-carboxamide compounds
JP7523404A JPH09510199A (ja) 1994-03-10 1995-03-08 キノリン−３−カルボキシアミド化合物の新規な使用
EE9600127A EE9600127A (et) 1994-03-10 1995-03-08 Kinoliin-3-karboksamiidi ühendite kasutamine uuel otstarbel
AU20887/95A AU679633B2 (en) 1994-03-10 1995-03-08 New use of quinoline-3-carboxamide compounds
EP95913458A EP0749310A1 (en) 1994-03-10 1995-03-08 New use of quinoline-3-carboxamide compounds
US08/704,587 US5726183A (en) 1994-03-10 1995-03-08 Use of quinoline-3-carboxamide compounds
ZA951966A ZA951966B (en) 1994-03-10 1995-03-09 Use of quinoline-3-carboxamide compounds
FI963531A FI963531A0 (fi) 1994-03-10 1996-09-09 Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
NO963762A NO963762D0 (no) 1994-03-10 1996-09-09 Ny anvendelse av kinolin-3-karboksamidforbindelser
KR1019960704979A KR970701546A (ko) 1994-03-10 1996-09-09 퀴놀린-3-카르복사미드 화합물의 새로운 용도(new use of quinoline-3-carboxamide compounds)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9400810A SE9400810D0 (sv) 1994-03-10 1994-03-10 New use of Quinoline-3-carboxamide compounds

Publications (1)

Publication Number Publication Date
SE9400810D0 true SE9400810D0 (sv) 1994-03-10

Family

ID=20393230

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9400810A SE9400810D0 (sv) 1994-03-10 1994-03-10 New use of Quinoline-3-carboxamide compounds

Country Status (11)

Country Link
US (1) US5726183A (ko)
EP (1) EP0749310A1 (ko)
JP (1) JPH09510199A (ko)
KR (1) KR970701546A (ko)
AU (1) AU679633B2 (ko)
CA (1) CA2185135A1 (ko)
EE (1) EE9600127A (ko)
FI (1) FI963531A0 (ko)
SE (1) SE9400810D0 (ko)
WO (1) WO1995024196A1 (ko)
ZA (1) ZA951966B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19746287A1 (de) * 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
US6077851A (en) * 1998-04-27 2000-06-20 Active Biotech Ab Quinoline derivatives
US6133285A (en) 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
US6121287A (en) * 1998-07-15 2000-09-19 Active Biotech Ab Quinoline derivatives
SE9802549D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
SE9802550D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
MX2013004169A (es) * 2010-10-14 2013-06-05 Immunahr Ab 1, 2-dihidro-4-hidroxi-2-oxo-quinolina-3-carboxanilidas como activadores del receptor de hidrocarburo aromatico.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1034124A (en) * 1973-05-11 1978-07-04 Ciba-Geigy Ag Process for the manufacture of new quinolines
FR2340735A1 (fr) * 1976-02-11 1977-09-09 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
SE8902076D0 (sv) * 1989-06-09 1989-06-09 Pharmacia Ab Derivatives of quinoline-3-carboxanilide
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide
SE9000624D0 (sv) * 1990-02-22 1990-02-22 Pharmacia Ab New use
SE9001111D0 (sv) * 1990-03-27 1990-03-27 Pharmacia Ab Supportive use
EP0575494A1 (en) * 1991-03-13 1993-12-29 Smithkline Beecham Corporation Leukotriene antagonists
SE469368B (sv) * 1991-10-09 1993-06-28 Kabi Pharmacia Ab Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)
JP3464731B2 (ja) * 1995-07-03 2003-11-10 バブコック日立株式会社 黒体膜付導光部を有するガス温度計測装置
JPH09114432A (ja) * 1995-10-20 1997-05-02 Brother Ind Ltd 色変換装置
JPH09112804A (ja) * 1995-10-23 1997-05-02 Ishikawajima Harima Heavy Ind Co Ltd 石炭焚ボイラの炉壁構造
GB2308133B (en) * 1995-12-13 2000-06-21 Kennametal Inc Cutting tool for machining titanium and titanium alloys
JPH09204325A (ja) * 1996-01-26 1997-08-05 Nec Telecom Syst Ltd ハードディスクのファイル配置方式
JPH09207833A (ja) * 1996-02-02 1997-08-12 Shin Caterpillar Mitsubishi Ltd 履帯式車輌の車高調整装置
JPH09306829A (ja) * 1996-05-16 1997-11-28 Sony Corp 走査型露光装置及び走査露光方法

Also Published As

Publication number Publication date
AU2088795A (en) 1995-09-25
WO1995024196A1 (en) 1995-09-14
JPH09510199A (ja) 1997-10-14
EE9600127A (et) 1997-04-15
US5726183A (en) 1998-03-10
ZA951966B (en) 1995-12-11
KR970701546A (ko) 1997-04-12
AU679633B2 (en) 1997-07-03
FI963531A (fi) 1996-09-09
EP0749310A1 (en) 1996-12-27
FI963531A0 (fi) 1996-09-09
CA2185135A1 (en) 1995-09-14

Similar Documents

Publication Publication Date Title
SE9302490D0 (sv) New use of old drugs
NZ333302A (en) Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor
DE69429984D1 (de) In position 3 durch eine stickstoffgruppe substituierte 1,3-dihydroindol-2-on derivate als vasopressin und/oder ocytocin agonisten und/oder antagonisten
CA2109613A1 (en) Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
EA199700117A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов
HK1021699A1 (en) Pentafluorobenzenesulfonamides and analogs.
GR3030992T3 (en) Selective system scan for multizone radiotelephone subscriber units.
SE9102909D0 (sv) New use
TW261616B (ko)
EA200500882A1 (ru) N-арилсульфонил-3-аминоалкоксииндолы
SE9400809D0 (sv) New use of quinoline-3-carboxamide compounds
SE9400810D0 (sv) New use of Quinoline-3-carboxamide compounds
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
CA2131831A1 (en) The use of quinoline-3-carboxamide compounds for treatment of diabetes
PH31442A (en) New chromene derivative compounds.
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel
ZA948352B (en) 3-aryl-4-alkyl and 4,5-dialkyl-4h-1,2,4-triazoles useful as memory enhancers
RU96119975A (ru) Новое применение соединений хинолин-3-карбоксамида
ES2101644A1 (es) Nuevo compuesto derivado del cromeno
NO963762L (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
NO963764L (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.